Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2005 1
2007 3
2011 2
2012 1
2013 6
2014 4
2015 3
2016 5
2017 2
2019 1
2020 5
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Results by year
Filters applied: . Clear all
Page 1
A bibliometric evaluation of the top 100 cited natalizumab articles.
García-Fernández FJ, García-Fernández AE, Nava E, Del Pozo JSG, Ikuta I, Jordan J, Galindo MF. García-Fernández FJ, et al. Among authors: nava e. J Neuroimmunol. 2020 Dec 15;349:577379. doi: 10.1016/j.jneuroim.2020.577379. Epub 2020 Sep 8. J Neuroimmunol. 2020. PMID: 33007648
Neurological Symptoms of COVID-19: The Zonulin Hypothesis.
Llorens S, Nava E, Muñoz-López M, Sánchez-Larsen Á, Segura T. Llorens S, et al. Among authors: nava e. Front Immunol. 2021 Apr 26;12:665300. doi: 10.3389/fimmu.2021.665300. eCollection 2021. Front Immunol. 2021. PMID: 33981312 Free PMC article. Review.
Cardiovascular diseases and the nitric oxide pathway.
Llorens S, Nava E. Llorens S, et al. Among authors: nava e. Curr Vasc Pharmacol. 2003 Oct;1(3):335-46. doi: 10.2174/1570161033476637. Curr Vasc Pharmacol. 2003. PMID: 15320480 Review.
Pharmaco-utilization of biologic drugs in patients affected by psoriasis, psoriatic arthritis and ankylosing spondylitis in an Italian real-world setting.
Zagni E, Colombo D, Fiocchi M, Perrone V, Sangiorgi D, Andretta M, De Sarro G, Nava E, Degli Esposti L. Zagni E, et al. Among authors: nava e. Expert Rev Pharmacoecon Outcomes Res. 2020 Oct;20(5):491-497. doi: 10.1080/14737167.2020.1800456. Epub 2020 Aug 23. Expert Rev Pharmacoecon Outcomes Res. 2020. PMID: 32701033
36 results